On 20 September 2022, the Ministry of Health in Uganda, together with the World Health Organization - Regional Office for Africa (WHO AFRO), confirmed an outbreak of Ebola virus disease (EVD) due to Sudan ebolavirus in Mubende District, Uganda.
This report provides an overview of the cases of hepatitis of unknown origin in children aged 16 years and below reported to ECDC and the WHO Regional Office for Europe through The European Surveillance System (TESSy).
The fifth meeting of the Hepatitis B and C Network aims to bring together experts from across the EU to discuss how Europe can improve its response to the epidemics of hepatitis B and C with a focus on surveillance, estimating prevalence, and the monitoring of response.
Recent epidemics of Ebola virus disease in Africa have increased the potential risk of Ebola virus transmission via donated blood and blood components, cells, tissues and organs (substances of human origin; SoHO), not only locally and regionally in Africa, but also in non-endemic unaffected areas such as Europe due to population movements.
Immunisation is the cornerstone of polio eradication. Two types of vaccine are available: an inactivated poliovirus vaccine (IPV) and a live attenuated OPV.
The key objective of this meeting was to verify the rationale and objectives of molecular typing for surveillance of hepatitis E virus (HEV) through the hepatitis E network (HEVnet). The workshop reviewed HEVnet as a tool for molecular surveillance of HEV in Europe.